Radiation Therapy

SABR for Prostate Cancer

Sunnybrook Health Sciences Centre, Toronto, Canada
SABRN/AWaitlist AvailableLed by Andrew Loblaw, MD, FRCPCResearch Sponsored by Sunnybrook Health Sciences Centre

Study Summary

This trial will study the prostate-specific quality of life of patients undergoing a two-fraction MRI-guided stereotactic ablative body radiation protocol.

Eligible Conditions
  • Prostate Cancer


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Secondary outcome measures
Acute Toxicity
Biochemical Recurrance
Health Utilities
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 2-fraction SABRExperimental Treatment1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 2

Find a site

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
633 Previous Clinical Trials
1,478,307 Total Patients Enrolled
32 Trials studying Prostate Cancer
12,152 Patients Enrolled for Prostate Cancer
Andrew Loblaw, MD, FRCPCPrincipal Investigator
Sunnybrook Health Sciences Centre, University of Toronto
1 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Prostate Cancer
30 Patients Enrolled for Prostate Cancer

Media Library

SABR (Radiation Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03588819 — N/A
Prostate Cancer Research Study Groups: 2-fraction SABR
Prostate Cancer Clinical Trial 2023: SABR Highlights & Side Effects. Trial Name: NCT03588819 — N/A
SABR (Radiation Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03588819 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently recruiting participants for this investigation?

"The information found on clinicaltrials.gov confirms that this medical study, posted April 23rd 2018 and last edited June 12th 2022 is not accepting patient applications at present. However, an impressive 1321 other trials are presently recruiting participants across the globe."

Answered by AI
~1 spots leftby Jan 2024